Different doses of nalmefene combined with hydromorphone hydrochloride for postoperative analgesia after colorectal surgery: a randomized controlled study

Ye Wang,Lin Zhao,Meng Wu,Qi An,Qianqian Guo,Chunling Fan,Zhenggang Guo
DOI: https://doi.org/10.1186/s12893-023-02293-z
2024-01-05
BMC Surgery
Abstract:Hydromorphone hydrochloride has a satisfactory postoperative analgesic effect for patients with colorectal cancer but is accompanied by a relatively high incidence of adverse events. Low-doses of naloxone combined with opioids for patient-controlled analgesia can reduce the incidence of drug-related adverse events. Nalmefene is a more selective opioid receptor antagonist than naloxone. The aim of this study was to determine the impact of low-doses of nalmefene on the analgesic effect and incidence of adverse events of patients with hydromorphone patient-controlled analgesia (PCA) undergoing colorectal radical surgery.
surgery
What problem does this paper attempt to address?